This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 13;9(4):190.

doi: 10.1038/nrclinonc.2012.32.

Chemotherapy: Reduced incidence of major bleeds with semuloparin

Lisa Hutchinson

PMID: 22411346
DOI: 10.1038/nrclinonc.2012.32

Comment

Chemotherapy: Reduced incidence of major bleeds with semuloparin

Lisa Hutchinson. Nat Rev Clin Oncol. 2012.

. 2012 Mar 13;9(4):190.

doi: 10.1038/nrclinonc.2012.32.

Author

Lisa Hutchinson

PMID: 22411346
DOI: 10.1038/nrclinonc.2012.32

No abstract available

PubMed Disclaimer

Comment on

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators. Agnelli G, et al. N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898. N Engl J Med. 2012. PMID: 22335737 Clinical Trial.

References

1. N Engl J Med. 2012 Feb 16;366(7):601-9 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.